Cargando…

244 : Homologous 2′,5′-phosphodiesterases from disparate RNA viruses antagonize antiviral innate immunity

Efficient and productive virus infection often requires viral countermeasures that block innate immunity. The interferon-inducible 2′,5-oligoadenylate (2-5A) synthetases (OAS) and ribonuclease L (RNase L) are components of a potent host antiviral pathway. We previously showed that murine coronavirus...

Descripción completa

Detalles Bibliográficos
Autores principales: Silverman, Robert H., Zhang, Rong, Jha, Babal K., Ogden, Kristen M., Dong, Beihua, Elliott, Ruth, Zhao, Ling, Patton, John T., Weiss, Susan R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129772/
http://dx.doi.org/10.1016/j.cyto.2013.06.247
_version_ 1783516860945268736
author Silverman, Robert H.
Zhang, Rong
Jha, Babal K.
Ogden, Kristen M.
Dong, Beihua
Elliott, Ruth
Zhao, Ling
Patton, John T.
Weiss, Susan R.
author_facet Silverman, Robert H.
Zhang, Rong
Jha, Babal K.
Ogden, Kristen M.
Dong, Beihua
Elliott, Ruth
Zhao, Ling
Patton, John T.
Weiss, Susan R.
author_sort Silverman, Robert H.
collection PubMed
description Efficient and productive virus infection often requires viral countermeasures that block innate immunity. The interferon-inducible 2′,5-oligoadenylate (2-5A) synthetases (OAS) and ribonuclease L (RNase L) are components of a potent host antiviral pathway. We previously showed that murine coronavirus (MHV) accessory protein ns2, a 2H phosphoesterase superfamily member, is a phosphodiesterase (PDE) that cleaves 2′,5′-oligoadenylates (2-5A) thereby preventing activation of RNase L (Zhao et al., Cell Host and Microbe 11:607–16, 2012). The PDE activity of ns2 is required for viral replication in macrophages and for hepatitis. Here, we will demonstrate that group A rotavirus, the primary cause of severe, dehydrating gastroenteritis in children worldwide, encodes an homologous and similar PDE. The VP3 carboxy-terminal domain (VP3-CTD) shares sequence and predicted structural homology with ns2, including two catalytic His-x-Thr/Ser motifs. Recombinant VP3-CTD also demonstrated 2′,5′-PDE activity, which cleaved 2-5A in vitro. In addition, its expression in cells depleted 2-5A levels induced by OAS activation with poly (rI):poly (rC), preventing RNase L activation. In the context of recombinant chimeric MHV expressing inactive ns2, the VP3-CTD restored the ability to replicate efficiently in macrophages or in the livers of infected mice, while chimeras expressing inactive VP3-CTD (H718A or H798R) were attenuated. Also, chimeric viruses expressing active ns2 or VP3, but not mutant ns2 or VP3, were able to protect ribosomal RNA from RNase L-mediated degradation. Thus, VP3-CTD is a 2′,5′-PDE able to functionally substitute for ns2 in the context of MHV infection. Remarkably, therefore, two disparate RNA viruses encode proteins with homologous 2′,5′-PDEs that antagonize innate immunity. In addition, based on sequence and predicted structural homology with MHV ns2 and rotavirus VP3, several other viruses have been identified that encode proteins with predicted 2′,5′-PDE activities.
format Online
Article
Text
id pubmed-7129772
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71297722020-04-08 244 : Homologous 2′,5′-phosphodiesterases from disparate RNA viruses antagonize antiviral innate immunity Silverman, Robert H. Zhang, Rong Jha, Babal K. Ogden, Kristen M. Dong, Beihua Elliott, Ruth Zhao, Ling Patton, John T. Weiss, Susan R. Cytokine Article Efficient and productive virus infection often requires viral countermeasures that block innate immunity. The interferon-inducible 2′,5-oligoadenylate (2-5A) synthetases (OAS) and ribonuclease L (RNase L) are components of a potent host antiviral pathway. We previously showed that murine coronavirus (MHV) accessory protein ns2, a 2H phosphoesterase superfamily member, is a phosphodiesterase (PDE) that cleaves 2′,5′-oligoadenylates (2-5A) thereby preventing activation of RNase L (Zhao et al., Cell Host and Microbe 11:607–16, 2012). The PDE activity of ns2 is required for viral replication in macrophages and for hepatitis. Here, we will demonstrate that group A rotavirus, the primary cause of severe, dehydrating gastroenteritis in children worldwide, encodes an homologous and similar PDE. The VP3 carboxy-terminal domain (VP3-CTD) shares sequence and predicted structural homology with ns2, including two catalytic His-x-Thr/Ser motifs. Recombinant VP3-CTD also demonstrated 2′,5′-PDE activity, which cleaved 2-5A in vitro. In addition, its expression in cells depleted 2-5A levels induced by OAS activation with poly (rI):poly (rC), preventing RNase L activation. In the context of recombinant chimeric MHV expressing inactive ns2, the VP3-CTD restored the ability to replicate efficiently in macrophages or in the livers of infected mice, while chimeras expressing inactive VP3-CTD (H718A or H798R) were attenuated. Also, chimeric viruses expressing active ns2 or VP3, but not mutant ns2 or VP3, were able to protect ribosomal RNA from RNase L-mediated degradation. Thus, VP3-CTD is a 2′,5′-PDE able to functionally substitute for ns2 in the context of MHV infection. Remarkably, therefore, two disparate RNA viruses encode proteins with homologous 2′,5′-PDEs that antagonize innate immunity. In addition, based on sequence and predicted structural homology with MHV ns2 and rotavirus VP3, several other viruses have been identified that encode proteins with predicted 2′,5′-PDE activities. Published by Elsevier Ltd. 2013-09 2013-08-14 /pmc/articles/PMC7129772/ http://dx.doi.org/10.1016/j.cyto.2013.06.247 Text en Copyright © 2013 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Silverman, Robert H.
Zhang, Rong
Jha, Babal K.
Ogden, Kristen M.
Dong, Beihua
Elliott, Ruth
Zhao, Ling
Patton, John T.
Weiss, Susan R.
244 : Homologous 2′,5′-phosphodiesterases from disparate RNA viruses antagonize antiviral innate immunity
title 244 : Homologous 2′,5′-phosphodiesterases from disparate RNA viruses antagonize antiviral innate immunity
title_full 244 : Homologous 2′,5′-phosphodiesterases from disparate RNA viruses antagonize antiviral innate immunity
title_fullStr 244 : Homologous 2′,5′-phosphodiesterases from disparate RNA viruses antagonize antiviral innate immunity
title_full_unstemmed 244 : Homologous 2′,5′-phosphodiesterases from disparate RNA viruses antagonize antiviral innate immunity
title_short 244 : Homologous 2′,5′-phosphodiesterases from disparate RNA viruses antagonize antiviral innate immunity
title_sort 244 : homologous 2′,5′-phosphodiesterases from disparate rna viruses antagonize antiviral innate immunity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129772/
http://dx.doi.org/10.1016/j.cyto.2013.06.247
work_keys_str_mv AT silvermanroberth 244homologous25phosphodiesterasesfromdisparaternavirusesantagonizeantiviralinnateimmunity
AT zhangrong 244homologous25phosphodiesterasesfromdisparaternavirusesantagonizeantiviralinnateimmunity
AT jhababalk 244homologous25phosphodiesterasesfromdisparaternavirusesantagonizeantiviralinnateimmunity
AT ogdenkristenm 244homologous25phosphodiesterasesfromdisparaternavirusesantagonizeantiviralinnateimmunity
AT dongbeihua 244homologous25phosphodiesterasesfromdisparaternavirusesantagonizeantiviralinnateimmunity
AT elliottruth 244homologous25phosphodiesterasesfromdisparaternavirusesantagonizeantiviralinnateimmunity
AT zhaoling 244homologous25phosphodiesterasesfromdisparaternavirusesantagonizeantiviralinnateimmunity
AT pattonjohnt 244homologous25phosphodiesterasesfromdisparaternavirusesantagonizeantiviralinnateimmunity
AT weisssusanr 244homologous25phosphodiesterasesfromdisparaternavirusesantagonizeantiviralinnateimmunity